NF1 and neurofibromatosis type 1: In addition to these clinical developments, the feasibility of CAR-T approaches for NF1 tumors has been comprehensively evaluated by Tang et al., who identified HER1 as a promising CAR-T target in NF1-associated nerve sheath tumors.